Results 171 to 180 of about 14,972 (184)

Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation

Human Mutation, 2004
Marco Tartaglia, Bruce Gelb, Alessandra Fragale   +2 more
exaly  

HETEROCYCLIC INHIBITORS OF PTPN11

2017
JONES PHILIP, CZAKO BARBARA, CROSS JASON, LEONARD PAUL, MSEEH FAIKA, PARKER CONNOR   +5 more
openaire   +5 more sources

Overexpression of Protein Phosphatase Non-receptor Type 11 (PTPN11) in Gastric Carcinomas

Digestive Diseases and Sciences, 2009
Jin Soo Kim, Sung Soo Kim, Chang Hyeok An   +2 more
exaly  

PTPN11 mutations in canine and human disseminated histiocytic sarcoma

International Journal of Cancer, 2020
Jean-Yves Blay, Benoit Hedan, Jean Donadieu   +2 more
exaly  

Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells

Blood, 2011
Wentian Yang, Michael Milyavsky, John Dick   +2 more
exaly  

PTPN11 (Protein Tyrosine Phosphatase, Nonreceptor Type 11) Mutations and Response to Growth Hormone Therapy in Children with Noonan Syndrome

Journal of Clinical Endocrinology and Metabolism, 2005
Ivo Arnhold, Berenice Mendonça
exaly  

PTPN11 Mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13

Human Mutation, 2002
John Belmont
exaly  

Somatic PTPN11 mutations in childhood acute myeloid leukaemia

British Journal of Haematology, 2005
Ivano Iavarone, Andrea Biondi, Marco Tartaglia   +2 more
exaly  

Induction of a Tumor-associated Activating Mutation in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhances Mitochondrial Metabolism, Leading to Oxidative Stress and Senescence

Journal of Biological Chemistry, 2013
Hong Zheng, Cheng-Kui Qu
exaly  

PTPN11 mutation with additional somatic alteration indicates unfavorable outcome in juvenile myelomonocytic leukemia: a retrospective clinical study from a single center

European Journal of Pediatrics, 2019
Hua Zhu, Benshang Li, Jianmin Wang
exaly